n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with lisuride in 4 studies
Studies (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Trials (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Recent Studies (post-2010) (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Studies (lisuride) | Trials (lisuride) | Recent Studies (post-2010) (lisuride) |
---|---|---|---|---|---|
14 | 0 | 0 | 756 | 80 | 31 |
Protein | Taxonomy | n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide (IC50) | lisuride (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.02 | |
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.041 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.559 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0003 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.016 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0029 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0005 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0043 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0005 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.173 | |
Histamine H2 receptor | Homo sapiens (human) | 1.04 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.041 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.003 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.02 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0005 | |
Histamine H1 receptor | Homo sapiens (human) | 0.16 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0002 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0051 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlsson, A; Ekman, A; Hoffmann, WE; Lum, JT; Piercey, MF; Svensson, K | 1 |
Clark, D; Ericsson, M; Furmidge, LJ; Johnson, D; Petry, N; Tong, ZY | 1 |
Spealman, RD | 1 |
Gerlach, J; Peacock, L | 1 |
4 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and lisuride
Article | Year |
---|---|
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Topics: 4-Butyrolactone; Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Ergolines; Lisuride; Male; Motor Activity; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Reserpine; Serotonin; Substantia Nigra; Time Factors | 1991 |
Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
Topics: Animals; Dextroamphetamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Lisuride; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior | 1991 |
Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.
Topics: Animals; Cocaine; Discrimination, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Receptors, Dopamine D2; Saimiri | 1995 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |